# Paragon Therapeutics, Inc. — Form D

Paragon Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-10. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-05-10
- Form: D
- Accession: 0000897069-21-000219
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 2
- Date of first sale: 2021-04-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-398700

## Issuer

- Name: Paragon Therapeutics, Inc.
- CIK: 0001861055
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: C/O FAIRMOUNT FUNDS MANAGEMENT, LLC, PHILADELPHIA, PA, 19103
- Phone: (267) 760-4066

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Peter Harwin | Director | West Conshohocken, PA |
| Evan Thompson | Executive Officer | Philadelphia, PA |
| Peter Harwin | Promoter | West Conshohocken, PA |
| Evan Thompson | Promoter | Philadelphia, PA |

## More

- [CIK 1861055 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1861055&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000897069-21-000219.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.